-
公开(公告)号:EP3459952A1
公开(公告)日:2019-03-27
申请号:EP17798784.9
申请日:2017-05-19
发明人: CHEN, Lei , GUAN, Dongliang , BAI, Hua , GOU, Jun , ZHAO, Weifeng , WANG, Zhongli , LING, Long , MA, Yutao
IPC分类号: C07D471/10 , C07D403/12 , C07D487/10 , A61K31/506 , A61P35/00
摘要: The present invention relates to a pyrimidine derivative, a method for preparing same and use thereof in medicine. In particular, the present invention relates to a pyrimidine derivative represented by general formula (I), a method for preparing same and a pharmaceutically acceptable salt thereof as well as use thereof as a therapeutic agent, in particular as a FGFR4 kinase inhibitor, definitions of each substituent in the general formula (I) being the same as those defined in the description.
-
公开(公告)号:EP4215525A1
公开(公告)日:2023-07-26
申请号:EP21868671.5
申请日:2021-09-16
发明人: QIU, Haibo , MA, Yutao , CHEN, Ahuan , ZHU, Yabo , ZHANG, Binhao , LU, Yongping , YE, Cheng , HU, Taishan , QIAN, Wenjian , CHEN, Lei
IPC分类号: C07D403/10 , A61K31/4425 , A61P7/02
摘要: The present invention relates to a piperazine derivative, a preparation method therefor, and use thereof in medicine. Specifically, the present invention relates to a piperazine derivative represented by general formula (I), a preparation method therefor, and a pharmaceutically acceptable salt or prodrug thereof, and use thereof as a therapeutic agent, in particular, as an inhibitor of coagulation factor XIa (FXIa), wherein the definition of each substituent in general formula (I) is the same as that in the description.
-
公开(公告)号:EP3998270A1
公开(公告)日:2022-05-18
申请号:EP20837650.9
申请日:2020-07-06
发明人: LV, Hejun , MA, Yutao , QIU, Haibo , ZHAO, Wenwen , HU, Taishan , CHEN, Lei
IPC分类号: C07D487/04 , A61K31/519 , A61K45/06 , A61P35/00 , A61P19/00 , A61P11/00 , A61P29/00 , A61P37/00 , A61P11/06 , A61P35/02
摘要: The present invention relates to an alkyne derivative, a preparation method for same, and applications thereof in medicine. Specifically, the present invention relates to the alkyne derivative as represented by formula (I), the preparation method for same, a pharmaceutically acceptable salt thereof, and uses of them as a therapeutic agent, specifically as a phosphoinositide 3-kinase γ (PI3Kγ) inhibitor, where the definitions of the substituents in formula (I) are identical to the definitions in the description.
-
-